How many drugs treat Chronic pain?

Drug Landscape tracks 6 marketed treatments for Chronic pain (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/chronic-pain.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Chronic pain — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic pain (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Chronic pain, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Subutex	BUPRENORPHINE	Purdue Pharma Lp	Partial Opioid Agonist	mu-opioid receptor, kappa-opioid receptor	1981-01-01
Subutex	Buprenorphine Hydrochloride	Indivior	partial opioid agonist	mu-opioid receptor, kappa-opioid receptor	1981-01-01
Opana Er	OXYMORPHONE	Endo	Opioid Agonist	Mu-type opioid receptor	1959-01-01
MS Contin	morphine sulfate	Generic (multiple manufacturers)	Opioid analgesic	Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor	1941-01-01
Naltrexon	Naltrexon	Institute of Liver and Biliary Sciences, India		Neuronal acetylcholine receptor subunit alpha-7, Cytochrome P450 2D6, Delta-type opioid receptor
Ultram	tramadol	Janssen		Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Chronic pain
Endo · 1 drug in Chronic pain
Generic (multiple manufacturers) · 1 drug in Chronic pain
Indivior · 1 drug in Chronic pain
Institute of Liver and Biliary Sciences, India · 1 drug in Chronic pain
Janssen · 1 drug in Chronic pain
Pfizer · 1 drug in Chronic pain
Purdue Pharma Lp · 1 drug in Chronic pain

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Chronic pain:

Cite this brief

Drug Landscape (2026). Chronic pain — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chronic-pain. Accessed 2026-06-10.

Chronic pain full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing